These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3029825)

  • 1. [31P NMR spectroscopy of muscular diseases: correlation with MR imaging].
    Kaiser WA; Hartl W; Sturm H; Schalke BC; Zeitler E
    Rofo; 1987 Feb; 146(2):137-44. PubMed ID: 3029825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nuclear magnetic resonance tomography in the diagnosis of muscular diseases].
    Kaiser WA; Schalke BC; Rohkamm R
    Rofo; 1986 Aug; 145(2):199-205. PubMed ID: 3018859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional staging of Duchenne muscular dystrophy using in vivo 31P MR spectroscopy.
    Ikehira H; Nishikawa S; Matsumura K; Hasegawa T; Arimizu N; Tateno Y
    Radiat Med; 1995; 13(2):63-5. PubMed ID: 7667509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR-tomography and -spectroscopy of skeletal muscles using high magnetic field strengths].
    Rodiek SO; Küther G; Juretschke HP; Hoepfel D; Schuff N
    Rofo; 1986 Jan; 144(1):89-95. PubMed ID: 3003848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 31P-NMR spectroscopy of myopathies: clinical application of whole-body MR.
    Itoh M; Iio M; Kawai M; Takizawa O; Yoshikawa K; Minami M; Ohtomo K; Aoki S; Niida T; Watanabe T
    Radiat Med; 1986; 4(2):41-5. PubMed ID: 3025940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy of normal and diseased muscles.
    Chance B; Younkin DP; Kelley R; Bank WJ; Berkowitz HD; Argov Z; Donlon E; Boden B; McCully K; Buist NM
    Am J Med Genet; 1986 Dec; 25(4):659-79. PubMed ID: 2947466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo P-31 NMR spectroscopy study of muscle metabolism in disease and under the influence of drugs].
    Jehenson P; Duboc D; Fardeau M; Syrota A
    Therapie; 1987 Sep; 42(5):467-70. PubMed ID: 2894723
    [No Abstract]   [Full Text] [Related]  

  • 8. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
    Griffiths RD; Cady EB; Edwards RH; Wilkie DR
    Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear magnetic resonance (NMR) in clinical diagnosis.
    Brady TJ; Koutcher JA
    Adv Intern Med; 1986; 31():419-46. PubMed ID: 3511626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophy and other myopathies. Troponin activity of natural actomyosin from skeletal muscle.
    Furukawa T; Peter JB
    Arch Neurol; 1972 May; 26(5):385-90. PubMed ID: 5026268
    [No Abstract]   [Full Text] [Related]  

  • 11. 1H and 31P nuclear magnetic resonance spectroscopy of erythrocyte extracts in myotonic muscular dystrophy.
    Gadoth N; Grinblat J; Shvo H; Navon G
    Isr J Med Sci; 1984 Aug; 20(8):672-6. PubMed ID: 6088426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis.
    Winguth S; Kurhanewicz J; Wang ML; Quivey JM; James TL; Char DH
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2417-22. PubMed ID: 2071353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle taurine in chicken and diseased human muscle.
    Airaksinen EM; Partanen J
    Prog Clin Biol Res; 1985; 179():407-12. PubMed ID: 4059221
    [No Abstract]   [Full Text] [Related]  

  • 14. Human skeletal muscle: sodium MR imaging and quantification-potential applications in exercise and disease.
    Constantinides CD; Gillen JS; Boada FE; Pomper MG; Bottomley PA
    Radiology; 2000 Aug; 216(2):559-68. PubMed ID: 10924586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of myometric findings in the morphological differential diagnosis of neuromuscular disorders (author's transl)].
    Pongratz D
    Microsc Acta Suppl; 1980; Suppl 4():38-43. PubMed ID: 6931279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromyography in the evaluation of muscle diseases.
    Buchthal F
    Neurol Clin; 1985 Aug; 3(3):573-98. PubMed ID: 3900682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
    Melchert UH; Brinkmann G; Förger K; Gleim M; Wunsch-Binder F; Maier C; Zick G
    Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle energy metabolism in female DMD/BMD carriers: a 31P-MR spectroscopy study.
    Barbiroli B; Funicello R; Ferlini A; Montagna P; Zaniol P
    Muscle Nerve; 1992 Mar; 15(3):344-8. PubMed ID: 1557082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormalities of the muscular bioenergetics in Steinert's disease].
    Kaminsky P; Robin-Lherbier B; Fener P; Jouanny P; Walker P; Klein M; Escanyé JM; Pourel J; Duc M
    Rev Neurol (Paris); 1993; 149(4):303-7. PubMed ID: 8235233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency analysis in clinical electromyography. Study in normal and myopathic subjects].
    Cosi V; Mazzella GL
    Riv Neurobiol; 1969; 15(3):422-70. PubMed ID: 5386490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.